
土耳其ImmunoGuide是AybayTech生物技術(shù)公司旗下的品牌,總部位于土耳其首都安卡拉,擁有自主生產(chǎn)基地,專注于高質(zhì)量體外診斷(IVD)ELISA試劑盒的研發(fā)、生產(chǎn)及市場推廣。該公司以其創(chuàng)新的藥物和抗藥物ELISA試劑盒聞名,核心產(chǎn)品用于監(jiān)測治療性單克隆抗體(如英夫利昔單抗、阿達(dá)木單抗等)的血藥濃度,并檢測患者血清或血漿中的抗藥物抗體水平,為精準(zhǔn)醫(yī)療提供關(guān)鍵數(shù)據(jù)支持。其產(chǎn)品符合歐洲與美國質(zhì)量標(biāo)準(zhǔn),多數(shù)試劑盒已獲得CE認(rèn)證,確保了其在世界市場的可靠性與競爭力。
ImmunoGuide的產(chǎn)品線十分豐富,主要涵蓋五大類:藥物和抗藥物ELISA試劑盒、免疫學(xué)試劑盒、酶聯(lián)免疫吸附試驗(yàn)(ELISA)試劑盒、快速診斷試劑盒以及免疫熒光試劑盒。這些產(chǎn)品廣泛應(yīng)用于臨床診斷、藥物研發(fā)、生物類似藥研究、治療藥物監(jiān)測(TDM)、環(huán)境檢測和食品安全等多個領(lǐng)域。其熱門產(chǎn)品如英夫利昔單抗(IG-AA101)、烏司奴單抗抗體(IG-BB121)和基于單克隆抗體的利妥昔單抗檢測試劑盒(IG-AB106),在設(shè)計(jì)上注重特異性,能有效避免交叉反應(yīng),適配血液、組織、細(xì)胞系等多種樣本類型。
該公司的核心優(yōu)勢在于其技術(shù)實(shí)力與高效的服務(wù)體系。其試劑盒采用優(yōu)化的算法,能有效降低背景噪音,提升弱陽性信號的識別能力。同時,公司擁有高效的供應(yīng)體系和穩(wěn)定的純化技術(shù),能保證產(chǎn)品的穩(wěn)定供應(yīng)。技術(shù)支持團(tuán)隊(duì)提供7×24小時在線答疑,并能處理緊急訂單,研發(fā)團(tuán)隊(duì)年均推出3-5款新品,緊跟CAR-T細(xì)胞監(jiān)測等免疫學(xué)研究熱點(diǎn)。在中國市場,上海起發(fā)實(shí)驗(yàn)試劑有限公司(BIOHUB INTERNATIONAL TRADE CO LTD)作為其代理,負(fù)責(zé)產(chǎn)品推廣、銷售及技術(shù)支持,有效期至2028年,為中國地區(qū)的科研機(jī)構(gòu)、三甲醫(yī)院及制藥企業(yè)提供了便捷的本土化服務(wù)渠道。
關(guān)鍵詞:Immunoguide,Immunoguide上海代理,Immunoguide中國代理,Immunoguide北京代理,Immunoguide江蘇代理, Immunoguide廣東代理、土耳其ImmunoGuide、AybayTech生物技術(shù)公司、藥物ELISA試劑盒、抗藥物抗體檢測、英夫利昔單抗定量、治療藥物監(jiān)測TDM、IVD體外診斷、CE認(rèn)證試劑盒、免疫熒光試劑盒、精準(zhǔn)診斷、臨床科研、生物類似藥分析、單克隆抗體檢測、腫瘤壞死因子α檢測、上海起發(fā)代理、酶聯(lián)免疫吸附試驗(yàn)、血清血漿檢測、自身免疫疾病診斷、細(xì)胞因子檢測、免疫學(xué)研究中心。
特別告知:為保證產(chǎn)品質(zhì)量與良好性能,所以在購買相應(yīng)產(chǎn)品的同時我司會收取一定量的運(yùn)輸費(fèi)用!??!本次報價有效時間為2025年12月19日---2026年12月20日。
(*此為部分產(chǎn)品價格,完整價格請下載文件)
貨號 | 品名 | 規(guī)格 | 價格 | 品牌 |
IG-AA107 | Golimumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AA103 | Adalimumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB107 | Golimumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AA101 | Infliximab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AA105 | Trastuzumab ELISA | 96Tests | 9350.00 | Immunoguide |
IG-AB121 | Ustekinumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AB112 | Cetuximab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AB111 | Omalizumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-BB102 | Antibody to Etanercept ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB102 | Etanercept ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AB110a | Ranibizumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AB103 | Adalimumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AA115 | Aflibercept ELISA | 96Tests | 9020.00 | Immunoguide |
IG-AA104 | Bevacizumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB101 | Infliximab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AB113 | Nivolumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-BB113 | Antibody to Nivolumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB121 | Antibody to Ustekinumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB116 | Antibody to Vedolizumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB108 | Antibody to Tocilizumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB101 | Antibody to Infliximab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB116 | Vedolizumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AA102 | Etanercept ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB106 | Antibody to Rituximab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB104 | Bevacizumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-AB108 | Tocilizumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB112 | Antibody to Cetuximab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB109 | Certolizumab Pegol ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-BB105 | Antibody to Trastuzumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB105 | Trastuzumab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-BB103 | Antibody to Adalimumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB107 | Antibody to Golimumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-BB104 | Antibody to Bevacizumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-AB106 | Rituximab ELISA (mAb-based) | 96Tests | 8800.00 | Immunoguide |
IG-BB111 | Antibody to Omalizumab ELISA | 96Tests | 8800.00 | Immunoguide |
IG-TA101 | Total Antibody to Infliximab | 96Tests | 8800.00 | Immunoguide |
IG-BB109 | Antibody to Certolizumab Pegol ELISA | 96Tests | 8800.00 | Immunoguide |

電話
微信